Transtheoretical model intervention for adherence to lipid-lowering drugs
Sara S Johnson1, Mary-Margaret Driskell, Janet L Johnson
1Pro-Change Behavior Systems, Inc., West Kingston, Rhode Island, USA. sjohnson@prochange.com
An expert system intervention using the Transtheoretical Model (TTM) significantly improved medication adherence and promoted healthier lifestyles in adults. This approach offers a population-wide strategy for enhancing adherence to lipid-lowering medications.
Area of Science:
- Behavioral Science
- Public Health
- Health Psychology
Background:
- Medication nonadherence affects 60% of patients, increasing health risks and costs.
- Improved adherence to lipid-lowering drugs is crucial for managing cardiovascular health.
Purpose of the Study:
- To evaluate the effectiveness of a Transtheoretical Model (TTM) expert system intervention on medication adherence.
- To assess the intervention's impact on exercise and dietary habits.
Main Methods:
- A randomized 18-month trial involving 404 adults compared a TTM expert system intervention to usual care.
- Participants were assessed for adherence, exercise, and diet stages.
Main Results:
- The TTM intervention significantly increased the proportion of participants in Action/Maintenance stages for adherence compared to usual care.
- Treatment participants showed sustained adherence benefits and higher rates of progression in exercise and diet.
- The intervention demonstrated significant positive effects on adherence and lifestyle changes at multiple time points.
Conclusions:
- Population-based Transtheoretical Model (TTM) expert system interventions are effective for improving medication adherence.
- The intervention shows promise for promoting concurrent improvements in diet and exercise, suggesting a holistic approach to health behavior change.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Bioavailability Enhancement: Drug Permeability Enhancement
Drug Therapy
Antianxiety Medications
Hypertension IV: Drug Therapy and Lifestyle Modifications
